San Francisco, CA, United States of America

Kurt Deshayes

USPTO Granted Patents = 7 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 137(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

patents

1 out of 80

Walter and Eliza Hall Institute of Medical Research

patents

where one patent can have more than one assignee

Years Active: 2006-2015

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8980837 - Inhibitors of IAP (2015-03-17),

2. 8907092 - Inhibitors of IAP (2014-12-09),

3. 8232273 - Heterocyclic compounds and methods of use (2012-07-31),

4. 8110568 - Inhibitors of IAP (2012-02-07),

5. 7432244 - Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides (2008-10-07),

6. 7244851 - Inhibitors of IAP (2007-07-17),

7. 7071300 - IGF antagonist peptides (2006-07-04),

Title: Inventor Kurt Deshayes: Pioneering Innovations in San Francisco

Introduction: Kurt Deshayes is a visionary inventor based in San Francisco, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Kurt Deshayes holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Kurt Deshayes has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Kurt Deshayes has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Kurt Deshayes continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of technological advancement.

This text is generated by artificial intelligence and may not be accurate.